Two-Headed PROTAC: An Effective New Tool for Targeted Protein Degradation

被引：43
|
作者：
Cyrus, Kedra [1 ]
Wehenkel, Marie [1 ]
Choi, Eun-Young [2 ]
Swanson, Hollie [2 ]
Kim, Kyung-Bo [1 ]
机构：
[1] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA
来源：
CHEMBIOCHEM | 2010年 / 11卷 / 11期
关键词：
estrogen receptor; ligases; PROTAC; proteomics; ubiquitin-proteasome pathway; ARYL-HYDROCARBON RECEPTOR; CHIMERIC MOLECULES; CHEMICAL GENETICS; UBIQUITINATION; BINDING; SCF;
D O I：
10.1002/cbic.201000222
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Better than one: A novel class of PROTAC that recruits target protein for ubiquitination and subsequent degradation by the proteasome has been successfully synthesized and tested for its activity to degrade a target protein. © 2010 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码：1531 / 1534
页数：4
相关论文
共 50 条
  • [1] PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
    Qi, Si-Min
    Dong, Jinyun
    Xu, Zhi-Yuan
    Cheng, Xiang-Dong
    Zhang, Wei-Dong
    Qin, Jiang-Jiang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [2] Battling the two-headed dragon of prostate cancer targeted therapy
    Wilkinson, Scott
    Sowalsky, Adam G.
    MOLECULAR & CELLULAR ONCOLOGY, 2020, 7 (04)
  • [3] Targeted protein degradation: elements of PROTAC design
    Paiva, Stacey-Lynn
    Crews, Craig M.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2019, 50 : 111 - 119
  • [4] Targeted Protein Degradation: Design Considerations for PROTAC Development
    Tran, Nathan L.
    Leconte, Georges A.
    Ferguson, Fleur M.
    CURRENT PROTOCOLS, 2022, 2 (12):
  • [5] PROTAC-induced protein structural dynamics in targeted protein degradation
    Wu, Kingsley Y.
    Hung, Ta, I
    Chang, Chia-en A.
    ELIFE, 2025, 13
  • [6] From PROTAC to TPD: Advances and Opportunities in Targeted Protein Degradation
    Wang, Siqi
    He, Fuchu
    Tian, Chunyan
    Sun, Aihua
    PHARMACEUTICALS, 2024, 17 (01)
  • [7] PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy
    Kelm, Jeremy M. M.
    Pandey, Deepti S. S.
    Malin, Evan
    Kansou, Hussein
    Arora, Sahil
    Kumar, Raj
    Gavande, Navnath S. S.
    MOLECULAR CANCER, 2023, 22 (01)
  • [8] Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
    Huifang Wang
    Runhua Zhou
    Fushan Xu
    Kongjun Yang
    Liuhai Zheng
    Pan Zhao
    Guangwei Shi
    Lingyun Dai
    Chengchao Xu
    Le Yu
    Zhijie Li
    Jianhong Wang
    Jigang Wang
    Biomaterials Research, 27
  • [9] Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
    Wang, Huifang
    Zhou, Runhua
    Xu, Fushan
    Yang, Kongjun
    Zheng, Liuhai
    Zhao, Pan
    Shi, Guangwei
    Dai, Lingyun
    Xu, Chengchao
    Yu, Le
    Li, Zhijie
    Wang, Jianhong
    Wang, Jigang
    BIOMATERIALS RESEARCH, 2023, 27 (01)
  • [10] PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
    Jeremy M. Kelm
    Deepti S. Pandey
    Evan Malin
    Hussein Kansou
    Sahil Arora
    Raj Kumar
    Navnath S. Gavande
    Molecular Cancer, 22
12345